Mixed Performance Highlights Strategic Adjustments and Diversified Strength What does a year of mixed financial results mean for a global claims management leader? Crawford & Company (NYSE: CRD-A and CRD-B) recently reported its financial results for the fourth quarter and…
Quanterix Corporation reports revenue growth, advances in Alzheimer’s diagnostics, and continued progress toward profitability in 2025. Quanterix Corporation , a global leader in ultra-sensitive biomarker detection technology, has reported financial results for the fourth quarter and full year ended December…
Q4 2025 Financial Results Highlight Strategic Shift to High-Density Colocation Why is the shift to high-density colocation critical for data centers today? Core Scientific, Inc. a leader in digital infrastructure for high-density colocation services, is making significant strides in this…
Myomo to Share Insights on Financial Performance and Strategic Initiatives What does the future hold for wearable medical robotics in the treatment of neurological disorders? Myomo, Inc. (NYSE American: MYO), a leading wearable medical robotics company, is set to report…
Axelspace Corporation, a Japanese microsatellite developer and operator guided by its mission of “Space at Your Fingertips,” has entered into a memorandum of understanding (MoU) with Jethi Software Development PLC, an Ethiopian technology firm, to collaborate on addressing pressing social…
Agenus Inc. , a leader in immuno-oncology innovation, announced the completion of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd., a transaction designed to accelerate the global development and potential commercialization of Agenus’ botensilimab and balstilimab (BOT+BAL) combination immunotherapy…
InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced the formation of a strategic research collaboration and licensing agreement focused on the development of a differentiated small-molecule therapeutic candidate for metabolic disease. The joint effort is designed to…
Sobi Exceeds 2025 Revenue and Adjusted EBITA Margin Outlook Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced that its full-year 2025 revenue and adjusted EBITA margin have surpassed the company’s previous outlook, reflecting strong performance across its portfolio. Full-year…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has released a comprehensive set of business and pipeline updates ahead of its scheduled investor meetings in January, underscoring strong commercial momentum and continued advancement across its research and development portfolio. These updates will be…
Kirin Develops Fermented Coffee Cherry Ingredient to Enhance Beverage Quality and Promote Sustainability Kirin Holdings Co., Ltd. announced that its Institute for Future Beverage has successfully developed a unique fermented ingredient derived from coffee cherries*1 — the red fruits of…